Shishir Bankapur
CEO

Helogen develops and operates fully automated, AI-enabled orbital factories to produce high-value biomaterials unattainable on Earth. By leveraging microgravity, the company achieves unprecedented material purity, yield, and carbon-positive scale. This orbital manufacturing capability establishes a new industrial frontier for advanced materials and medicines.
Funding not disclosed

CEO
Traditional research and development processes for pharmaceuticals, cosmetics, and other biological products can be lengthy and costly due to the limitations of Earth-based environments. Replicating certain biological processes and aging effects in a lab setting can take years, hindering the pace of innovation and time to market.
Odyssey SpaceWorks provides a satellite-based laboratory platform that leverages the unique microgravity environment of space to accelerate biological processes and fast-track breakthroughs in healthcare, wellness, and cosmetics. Their platform enables accelerated aging studies, faster organoid growth, and optimized microbial output, reducing development time and costs. By offering a turnkey solution that includes hardware, logistics, and regulatory approvals, Odyssey SpaceWorks allows companies to conduct research and development in space without the complexities typically associated with space-based experimentation. The platform supports a range of applications, from drug discovery and preclinical oncology to cosmetics formulation and biosecurity threat mitigation.
The primary target audience includes companies in the pharmaceutical, cosmetics, wellness, agriculture, and biosecurity industries seeking to accelerate research and development, optimize product performance, and reduce time to market.